Adapalene plus hyaluronic acid gel for mild to moderate acne
Part of Skin clinical trials.
This trial compares a gel containing adapalene (a retinoid) plus hyaluronic acid (a moisturizer) to adapalene gel alone for mild to moderate acne. It aims to see if adding hyaluronic acid helps reduce irritation and improve results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have mild to moderate acne (not severe or cystic).
- You haven't used prescription acne creams or acne pills in the last 3 months.
- You are not allergic to adapalene or hyaluronic acid.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two gels applied to the face to treat mild to moderate acne. One gel contains spironolactone, a medicine that blocks hormones that cause acne, and the other contains adapalene, a common acne treatment. The goal is to see which works better.
This trial tests three different gel treatments for mild to moderate acne on the face. One gel contains clindamycin and retinoid, another adds dexamethasone, and the third uses a special stem-cell secretion. All are applied to the face for 8 weeks.
This trial tests a new acne cream called clascoterone compared to a standard cream, adapalene, for mild acne. It aims to see which one works better for clearing pimples.
This trial tests if a new cleanser and cream combination can safely treat mild to moderate acne. It may help people who have not used other acne treatments recently.
This study tests if metronidazole gel or clindamycin gel works better for people with moderate acne. It aims to find a good treatment option for you.
This study compares a new dutasteride gel to a standard acne triple-combination gel for treating facial acne in adults. It aims to find a more effective topical treatment.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.